TIBER CREEK GROUP for ASTELLAS PHARMA US, INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to the pharmaceutical sales fee for Medicare Part B. Issues related to the renewal of the R&D tax credit.
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| SHEILA MURPHY | — |
| SEAN RICHARDSON | — |
Copyright/Patent/Trademark CPT
Issues related to S.23/H.R. 1249, America Invents Act.
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| SHEILA MURPHY | — |
| SEAN RICHARDSON | — |
Health Issues HCR
Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152) Issues related to the development of new antibiotics. Issues related to the supply of medical isotopes (S. 99, the American Medical Isotopes Production Act). Issues related to reauthorization of the Prescription Drug User Fee Act. Issues related to cancer research and treatment. Issues related to drug safety.
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| SHEILA MURPHY | — |
| SEAN RICHARDSON | — |
Medicare/Medicaid MMM
Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152).
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| SHEILA MURPHY | — |
| SEAN RICHARDSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.